ATGL vs NVDA

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability. Despite a strong gross margin of 54.06% and a healthy current ratio of 4.18, the company is unprofitable with deeply negative operating and net margins, collapsing revenue growth of -49.30% YoY, and extremely elevated valuation multiples. The absence of Altman Z-Score and key valuation metrics like Graham Number further underscores data limitations and financial opacity. Recent price performance shows a sharp reversal from long-term gains, with significant declines over the past 6 months and 1 month, suggesting deteriorating market confidence.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.